loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 22061 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE (1)

filter

01 MATRIX LABS (1)

filter

01 TABLET; ORAL (1)

filter

01 150MG; 200MG; 300MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET; ORAL
150MG; 200MG; 300MG
LAMIVUDINE; NEVIRAPINE...
USA
22061
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22061

Looking for CTD TGA MCC DOSSIER APPLICATION 22061 1

19

MATRIX LABORATORIES XIAMEN LTD., based in China, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE, with a corresponding application number 22061 and regulatory information .

proudly manufactured in the

MATRIX LABORATORIES XIAMEN LTD.'s LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL, medication with 150MG; 200MG; 300MG of LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE.

Post Enquiry
POST ENQUIRY